Virtu Financial LLC 180 Life Sciences Corp. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.81 - $2.53 $11,705 - $36,561	14,451 New	14,451 $12,000
Q1 2022 May 17, 2022	SELL	$2.53 - $3.9 $109,769 - $169,209	-43,387 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$3.27 - $6.38 $141,875 - $276,809	43,387 New	43,387 $169,000
Q3 2021 Nov 12, 2021	SELL	$5.11 - $10.81 $130,279 - $275,600	-25,495 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$6.7 - $11.98 $25,975 - $46,446	-3,877 Reduced 13.2%	25,495 $255,000
Q1 2021 May 19, 2021	BUY	$2.51 - $6.96 $73,723 - $204,429	29,372 New	29,372 $193,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $70.5M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.